Latest news

May 9, 2022

Debiopharm leads investment round for evidence-based digital cancer therapeutic app Mika to empower cancer patients

Read more
March 30, 2022

VivoSense Announces Closing of $25M Series A Financing Round Co-led by Xontogeny and Debiopharm

Read more
February 8, 2022

Challenge pour la Qualité de vie du patient 2022 : l’appel à projets est ouvert !

Read more
February 1, 2022

Debiopharm and Aspen Partner to Launch Prostate Cancer Drug Trelstar® in South Africa

Read more
January 10, 2022

Debiopharm invests in VeriSIM Life’s $15m series A round to advance AI-enabled drug research

Read more
December 16, 2021

Debiopharm further explores the potential of its potent, highly selective WEE1 inhibitor Debio 0123 in phase 1 cancer study

Read more
December 6, 2021

Grand gagnant du 6eme Challenge 2021 pour la qualité de vie du patient, le projet WheelyWasher permet de nettoyer automatiquement…

Read more
November 9, 2021

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…

Read more
October 19, 2021

CARB-X Funds The 3rd Round of Debiopharm’s Targeted Antibiotic Program To Combat Resistant N. Gonorrhoeae Infections

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.